Subject: FW: Re: hepatitis C
From: Ekaterine Adamia <[email-masked]>
To: Mariana Mkurnali <[email-masked]>
Date: Wed, 05 Jul 2017 10:02:17 +0000

-----Original Message-----
From: Marina Darakhvelidze [mailto:[email-masked]] 
Sent: 2017 წლის 04 07, სამშაბათი 18:18
To: Ekaterine Adamia
Subject: Fwd: Re: hepatitis C

ალბათ, ასეთი წერილი არასაკმარისია. ვეტყვი, სესია რომ დასრულდება, რომ ოფიციალური გზავნილი გვჭირდება... 

-----Original Message-----
From: Igor Karpov <[email-masked]>
To: Marina Darakhvelidze <[email-masked]>
Date: Tue, 4 Jul 2017 17:10:40 +0300
Subject: Re: hepatitis C

> Вторник,  4 июля 2017, 14:15 +02:00 от "Marina
Darakhvelidze" <[email-masked]>:
> Dear Marina! Thank you for your letter and collaboration. I try to
answer your questions:
    1. Selection of benifiars: mostly people with F3-F4; genotipe 2-3 (possible combination with ribavirin);
        HIV -infected, women before 45 (planing pregnancy), medical staff
    2. This people were diagnosed previously with testing genotype, fibrosis, viral load
    3.  500 patients receive treatment
    4.   Patients receive one box monthly
    5.   It is personal control of Head of clinic (signature of patients,
video control /where is possible/ collective 
> prescription, medical documents). Control of Ministry of Health>  We
have real system of control medicines in Infectious Hospitals since 1997.
    6. I have no primary results (too early)
    7. Yes, we have three documents, which reglamints this work - level of the Ministry:A. Order of the Ministry; B. Methodological letter for selection of patients C. Instruction for use DAA

Dear Igor,
> 
>  I would like to ask you help us - Georgian side  need information 
> from Ministry of Health of Belarus about the contemporary medicines 
> for
treatment 
> hepatitis C, according agreement between our countries:
> 
> 1. How were selected the beneficiaries (criteria for selection?) 2. 
> Were the laboratory tests conducted or not (without/with funding)?
If they 
> have been already diagnosed?
> 3. How many beneficiaries have received Sovaldy?
> 4. How the medicines  were  distributed  (three boxes together? Or one
box 
> monthly?)
> 5. How they control distribution? do they have control  results? Do 
> you
have a 
> treatment monitoring mechanism?
> 6. Do you have primary results?
> 7. Is there a project document, approved by minister? Or by government?
> 
> With best regards,
> 
> Marina Darakhvelidze
> 
> Head of Health Care Department
> Ministry of Labour, Health and Social Affairs of Georgia
> 
> mob.:+995 577 722 642
> 
> 
> 

С уважением,
Igor Karpov
[email-masked]